PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Atropine sulfate - Hypersalivation in adults

PAD Profile : Atropine sulfate - Hypersalivation in adults

Keywords :
excessive saliva, hypersialosis, drooling, sialorrhoea

Traffic Light Status

Status 1 of 2.

Status :
Blue
Important
Formulations :
  • Eye drops
  • Sub-lingual drops
Important Information :
Off-label use. 1% Eye drops used sublingually. NOTE - the bottles (5ml / 10ml) are VERY expensive in primary care (>£150 per bottle) and should only be used where the unit dose Minims is not suitable and atropine is the required therapy. Primary Care may prescribe on request from the specialist team.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
Un
Comments :
No comments returned.
Documents :

Status 2 of 2.

Status :
Blue
Important
Formulations :
  • Eye drops (unit dose)
  • Sub-lingual drops
Important Information :
1% Minims eye drops used sublingually. Each unit dose can continue to be used for 24 hours after opening (multiple doses). One Minims unit per day. Off-label use. Primary Care may prescribe on request from the specialist team.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
Un
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

No additional documents returned.

Committee Recommendations

No committee recommendations returned.

Associated BNF Codes

11. Eye
11.05.00. Mydriatics and cycloplegics
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More